Senior Scientific Manager
Syd manages the high-throughput operations within the Garnett Group. These include drug sensitivity screens both single agents and combinations in cell line and organoids models as well as CRISPR knockout screens. He has over ten years of cancer research experience working on high-throughput genomic & cell based projects at the Sanger Institute. In addition Syd helped to establish the Cell Model Passports, a website providing annotation, genomics and functional datasets for the cancer models used as part of the Cancer Dependency Map at Sanger.